Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Sensei Biotherapeutics, Inc. (SNSE) had Income from Continuous Operations of $-6.86M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.86M |
|
-- |
|
-- |
|
$7.27M |
|
$-7.27M |
|
$0.41M |
|
$-6.86M |
|
$-6.88M |
|
$-6.86M |
|
|
Income from Continuous Operations |
$-6.86M |
$-6.86M |
|
$-6.88M |
|
$-7.27M |
|
$-7.24M |
|
25.19M |
|
25.19M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$35.68M |
|
$0.16M |
|
$2.59M |
|
$38.27M |
|
$5.23M |
|
$0.04M |
|
$1.06M |
|
$6.29M |
|
$31.99M |
|
$31.99M |
|
$31.99M |
|
25.21M |
|
| Cash Flow Statement Financials | |
$-7.09M |
|
$7.19M |
|
$-0.21M |
|
$9.99M |
|
$9.88M |
|
$-0.12M |
|
$0.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.82 |
|
-- |
|
-- |
|
0.00 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.46% |
|
-21.46% |
|
-17.93% |
|
-21.44% |
|
$1.27 |
|
$-0.28 |
|
$-0.28 |
|